MISSION Rx Act

Overview

HR 8667, the MISSION Rx Act, is a bill introduced in the 119th Congress with bipartisan House sponsorship. The legislation aims to address issues related to veterans’ access to prescription medications and the broader coordination of medical benefits and services for active-duty and veteran populations. The exact text of the bill is not provided here, but the title and the bill’s inclusion in the Veterans’ Affairs and Armed Services committee tracks suggest a focus on medical access, pharmaceutical management, and related support services for service members and veterans.

Purpose and Intent

• Improve access to prescription medications for military personnel, veterans, and potentially their families.
• Streamline or coordinate pharmaceutical benefits across relevant federal programs (e.g., Department of Veterans Affairs, Department of Defense health systems) to reduce gaps, delays, or duplications.
• Enhance oversight or administration of Rx benefits to ensure timely and affordable access to needed medicines.
• Possibly address issues related to drug pricing, formulary participation, or pharmacy benefit management within the federal veterans’ and military health systems.

Key Provisions and Changes (illustrative, based on title and typical scope)

Note: Specific text is not provided in the prompt. The following points are common elements in bills with similar aims and may be illustrative of potential provisions. For precise language, refer to the bill text.

• Coordination of Benefits: Establish mechanisms to better align prescription drug benefits across the Department of Veterans Affairs (VA) and the Department of Defense (DoD), and potentially the Department of Health and Human Services (HHS) programs that interact with veterans’ care.
• Access Improvements: Provisions to reduce formulary barriers, streamline prior authorization processes, and expedite prescription fulfillment for eligible beneficiaries.
• Cost and Access Safeguards: Measures to control out-of-pocket costs, cap certain copays, or improve access to affordable medications for veterans and active-duty personnel.
• Stakeholder Engagement: Requirements for consultation with VA, DoD, veterans service organizations, and healthcare providers to assess and monitor Rx access issues.
• Reporting and Accountability: New reporting requirements to Congress on prescription drug access metrics, wait times, formulary changes, and beneficiary satisfaction.
• Implementation Timeline: A phased timeline for implementing new coordination or programmatic changes, including pilot programs or transition periods.

Who Would Be Affected

• Service members on active duty and their families, who rely on DoD health services.
• Veterans who receive care or benefits through the VA health system.
• Healthcare providers and pharmacies that participate in DoD and VA prescription programs.
• Administrators and policymakers within the VA and DoD responsible for pharmacy benefits management and formulary decisions.
• Potentially, contractors or private sector partners involved in pharmacy benefit management or drug supply chains.

Procedural and Timeline Aspects

• Introduction: HR 8667 was introduced in May 2026.
• Referral: Referred to the House Committee on Veterans’ Affairs and, in addition, to the Committee on Armed Services, for consideration of provisions within their jurisdiction.
• Next Steps (typical): The committees would review, hold hearings, and mark up the bill before it proceeds to full House consideration. If advanced, the bill would move through the legislative process toward floor votes and potential reconciliation with Senate counterparts.

Potential Impacts

• Improved access to prescribed medications for veterans and service members, potentially reducing delays and administrative barriers.
• More coordinated and transparent management of prescription drug benefits across military and veteran health systems.
• Possible cost containment or patient-out-of-pocket savings for beneficiaries, depending on final provisions.
• Enhanced accountability and performance metrics related to Rx access and formulary management.

If you can provide the bill text or a link to the official summary, I can refine this into a precise section-by-section analysis with exact provisions, dollar amounts, timelines, and impacted programs.